MMS (Maximus) Other Long-Term Liabilities: $24 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MMS Maximus Inc MMS
77 GF Score
Price $57.76
GF Value $89.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Maximus Other Long-Term Liabilities?

Maximus MMS -1.10% 77 Other Long-Term Liabilities is $24 Mil as of Jun. 2026. GuruFocus rates MMS with a GF Score™ of 77/100 and a GF Value™ of $89.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Maximus's other long-term liabilities for the quarter that ended in Jun. 2026 was $24 Mil.

Maximus's quarterly other long-term liabilities increased from Dec. 2025 ($22 Mil) to Mar. 2026 ($24 Mil) and increased from Mar. 2026 ($24 Mil) to Jun. 2026 ($24 Mil).

Maximus's annual other long-term liabilities increased from Sep. 2023 ($13 Mil) to Sep. 2024 ($20 Mil) and increased from Sep. 2024 ($20 Mil) to Sep. 2025 ($23 Mil).

Maximus Other Long-Term Liabilities Related Terms

Maximus Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Maximus's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maximus Other Long-Term Liabilities Chart

Maximus Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.32 22.51 13.25 20.20 22.64

Maximus Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.58 22.64 22.04 23.53 24.00
MMS
77GF Score
Maximus Inc MMS
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maximus Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $24 Mil mean?
Maximus (MMS) has a Other Long-Term Liabilities of $24 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Maximus and its competitors.
Is Maximus' Other Long-Term Liabilities too high?
Maximus' current Other Long-Term Liabilities is $24 Mil. Overall, Maximus has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maximus' Other Long-Term Liabilities compare to FA and ABM?
Maximus' Other Long-Term Liabilities of $24 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Business Services company?
A good Other Long-Term Liabilities depends on the Business Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Maximus and its competitors. Maximus's current Other Long-Term Liabilities is $24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maximus stock overvalued right now?
Based on GuruFocus' analysis, Maximus (MMS) is currently considered Significantly Undervalued. The stock's GF Value™ is $89.95, compared to a current price of $57.76 — trading 35.8% below its estimated fair value. The current Other Long-Term Liabilities is $24 Mil. Maximus' overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Maximus (MMS), the current Other Long-Term Liabilities is $24 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maximus (MMS) Overvalued in 2026?

Based on GuruFocus' analysis, Maximus stock appears to be undervalued. The current stock price of $57.76 is trading 35.8% below its estimated GF Value™ of $89.95. GuruFocus considers Maximus to be Significantly Undervalued.

Key valuation signals for MMS:

  • Other Long-Term Liabilities: $24 Mil
  • GF Value™: $89.95 vs. price of $57.76 (35.8% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the MMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maximus Business Description

Other Exchanges MMY:Germany
Address 1600 Tysons Boulevard, McLean, VA, USA, 22102
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
77GF Score

Get the complete analysis for MMS

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$57.76
Price
$89.95
GF Value